← Back to Clinical Trials
Recruiting NCT07247409

NCT07247409 Establishment of Hong Kong Diabesity Register

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07247409
Status Recruiting
Phase
Sponsor Chinese University of Hong Kong
Condition Diabesity
Study Type OBSERVATIONAL
Enrollment 800 participants
Start Date 2025-10-22
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 50 Years
Study Type OBSERVATIONAL
Interventions
No Intervention: Observational Cohort

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 800 participants in total. It began in 2025-10-22 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

All participants of the Diabesity Register will receive structured assessment by nurses guided by the JADE portal at baseline including eye, feet, blood and urine examination with evaluation of BMI, blood pressure, HbA1c, lipid profile, renal and liver function tests, urine for albumin-creatinine ratio. All patients will return at 3-year for a repeat assessment of physical and psychological health, as well as changes over time.

Eligibility Criteria

Inclusion Criteria: 1. Type 2 diabetes; 2. Obesity reaching action level as defined as body mass index (BMI) 27.5 kg/m2 and/or waist circumference (WC) 80cm in women and 90cm in men; 3. Age between 18 and 50 years; 4. Able to conversate with smartphone technology and web-based program. 5. Able to read Chinese and communicate using Chinese. Exclusion Criteria: 1. Type 1 diabetes; 2. Active malignant disease including those with history of malignant disease less than 5 years of disease-free duration; 3. Life expectancy less than 12 months; 4. Any medical illness or condition as judged by the investigators as ineligible to participate the study.

Contact & Investigator

Central Contact

Alice Pik Shan Kong, MD

✉ alicekong@cuhk.edu.hk

📞 +852 3505 2648

Frequently Asked Questions

Who can join the NCT07247409 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Diabesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07247409 currently recruiting?

Yes, NCT07247409 is actively recruiting participants. Contact the research team at alicekong@cuhk.edu.hk for enrollment information.

Where is the NCT07247409 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT07247409 clinical trial?

NCT07247409 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 800 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology